Hikma Pharmaceuticals (HIK)

 

Latest News

Holding(s) in Company

RNS Number: 6169A Hikma Pharmaceuticals Plc 27 March 2017 Notification of major interests in shares LONDON, 27 March 2017 - Hikma Pharmaceuticals PLC ("Hikma") (LSE: HIK) (DIFX: HIK), the fast growing multinational pharmaceuticals group, announces as follows: 1 Identity of the issuer or the underlying issuer of existing shares to which the voting right...

FTSE recovers despite Trump healthcare concerns

The blue-chip index recovered some ground this afternoon as investors put concerns over a potential legislative roadblock f...

Director/PDMR Shareholding

RNS Number: 3051A Hikma Pharmaceuticals Plc 23 March 2017 Notification and public disclosure of transactions by persons discharging managerial responsibilities The attached individual notification made under article 19.1 of the Market Abuse Regulation (" MAR ") relates to the disposal of Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC by the ...

Broker views: Pharmaceuticals

HSBC has downgraded its recommendation on Hikma Pharma (LON:HIK) to reduce (from hold) saying that it remains co...

All News

DateHeadlineSource
27-03-17Holding(s) in CompanyRNS
23-03-17FTSE recovers despite Trump healthcare concerns StockMarketWire
23-03-17Director/PDMR ShareholdingRNS
17-03-17Broker views: PharmaceuticalsStockMarketWire
17-03-17Broker Forecast - Peel Hunt issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
17-03-17Broker Forecast - HSBC issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
16-03-17Broker Forecast - JP Morgan Cazenove issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
15-03-17Miners dominate FTSE on upbeat Chinese dataStockMarketWire
15-03-17FTSE tends higher ahead of Fed as Hikma flies StockMarketWire
15-03-17Hikma core operating profits upStockMarketWire
15-03-17Final ResultsRNS
10-03-17Broker Forecast - Numis issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
10-03-17FTSE up with BT.A shining amid rising miners, oiliesStockMarketWire
10-03-17Hikma unit launches antidepressant in US StockMarketWire
10-03-17Hikma launches Desvenlafaxine Succinate TabletsRNS
08-03-17Notice of ResultsRNS
08-03-17Director/PDMR ShareholdingRNS
01-03-17Total Voting RightsRNS
13-02-17Hikma inks licensing deal with Orion for EasyhalerStockMarketWire
13-02-17Licensing agreement with Orion for Easyhaler?RNS
06-02-17Total Voting RightsRNS
06-02-17Holding(s) in CompanyRNS
25-01-17Broker Forecast - Peel Hunt issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
18-01-17Hikma unit gets FDA approval for narcolepsy drug StockMarketWire
18-01-17Hikma receives approval for Sodium OxybateRNS
04-01-17Broker Forecast - JP Morgan Cazenove issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
29-12-16The market's on a last minute bargain huntInteractive Investor
20-12-16Director/PDMR ShareholdingRNS
20-12-16Director Deals - Hikma Pharmaceuticals PLC (HIK)StockMarketWire
20-12-16Director Deals - Hikma Pharmaceuticals PLC (HIK)StockMarketWire
20-12-16Director Deals - Hikma Pharmaceuticals PLC (HIK)StockMarketWire
20-12-16Holding(s) in CompanyRNS
20-12-16Director/PDMR ShareholdingRNS
15-12-16Broker Forecast - Jefferies International issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
13-12-16Director Deals - Hikma Pharmaceuticals PLC (HIK)StockMarketWire
13-12-16Director Deals - Hikma Pharmaceuticals PLC (HIK)StockMarketWire
13-12-16Director Deals - Hikma Pharmaceuticals PLC (HIK)StockMarketWire
13-12-16Director Deals - Hikma Pharmaceuticals PLC (HIK)StockMarketWire
13-12-16Director/PDMR ShareholdingRNS
12-12-16Director/PDMR ShareholdingRNS

RSS feeds

  • Editorial news feed for LSE:HIK Editorial
  • Regulatory news feed for LSE:HIK Regulatory